1.56
price down icon0.64%   -0.01
after-market Handel nachbörslich: 1.64 0.08 +5.13%
loading

Acumen Pharmaceuticals Inc Aktie (ABOS) Neueste Nachrichten

pulisher
Jan 29, 2025

Acumen Pharmaceuticals chief medical officer sells $5,118 in shares - MSN

Jan 29, 2025
pulisher
Jan 29, 2025

Acumen Pharmaceuticals chief legal officer sells shares worth $5,434 - MSN

Jan 29, 2025
pulisher
Jan 25, 2025

Acumen Pharmaceuticals COO Barton Russell sells shares worth $4,692 - MSN

Jan 25, 2025
pulisher
Jan 24, 2025

Matt Zuga Sells 28,902 Shares of Acumen Pharmaceuticals, Inc. (NASDAQ:ABOS) Stock - MarketBeat

Jan 24, 2025
pulisher
Jan 24, 2025

Acumen Pharmaceuticals, Inc. (NASDAQ:ABOS) CEO Daniel Joseph Oconnell Sells 12,619 Shares - MarketBeat

Jan 24, 2025
pulisher
Jan 24, 2025

Acumen Pharmaceuticals CEO O'Connell sells shares worth $20,102 - MSN

Jan 24, 2025
pulisher
Jan 24, 2025

Acumen Pharmaceuticals CFO sells shares totaling $56,619 - MSN

Jan 24, 2025
pulisher
Jan 24, 2025

Analysts Set Expectations for ABOS FY2025 Earnings - Defense World

Jan 24, 2025
pulisher
Jan 23, 2025

Acumen Pharmaceuticals CFO sells shares totaling $56,619 By Investing.com - Investing.com South Africa

Jan 23, 2025
pulisher
Jan 23, 2025

Acumen Pharmaceuticals CEO O'Connell sells shares worth $20,102 By Investing.com - Investing.com Canada

Jan 23, 2025
pulisher
Jan 23, 2025

Brokers Offer Predictions for ABOS FY2025 Earnings - MarketBeat

Jan 23, 2025
pulisher
Jan 23, 2025

Acumen Pharmaceuticals, Inc. (NASDAQ:ABOS) Stock Holdings Lifted by Barclays PLC - Defense World

Jan 23, 2025
pulisher
Jan 20, 2025

Short Interest in Acumen Pharmaceuticals, Inc. (NASDAQ:ABOS) Expands By 9.1% - Defense World

Jan 20, 2025
pulisher
Jan 17, 2025

Acumen stock touches 52-week low at $1.54 amid market challenges - MSN

Jan 17, 2025
pulisher
Jan 17, 2025

Acumen stock touches 52-week low at $1.54 amid market challenges By Investing.com - Investing.com South Africa

Jan 17, 2025
pulisher
Jan 09, 2025

Acumen Pharmaceuticals Announces Journal of Prevention of Alzheimer's Disease Publication of the Company's Phase 1 INTERCEPT-AD Study, Including Target Engagement, Dosing Regimen and Safety Findings - The Manila Times

Jan 09, 2025
pulisher
Jan 09, 2025

Acumen Pharmaceuticals Announces Journal of Prevention of Alzheimer’s Disease Publication of - The Bakersfield Californian

Jan 09, 2025
pulisher
Jan 09, 2025

Acumen's Alzheimer's Drug Shows Promise: Phase 1 Trial Reveals Strong Safety Profile, Plaque Reduction - StockTitan

Jan 09, 2025
pulisher
Jan 08, 2025

Acumen Pharmaceuticals CFO Zuga Matt sells $24,366 in stock By Investing.com - Investing.com Australia

Jan 08, 2025
pulisher
Jan 08, 2025

Acumen Pharmaceuticals' chief legal officer sells $20,505 in stock By Investing.com - Investing.com Australia

Jan 08, 2025
pulisher
Jan 08, 2025

Acumen Pharmaceuticals, Inc. (NASDAQ:ABOS) Shares Purchased by Geode Capital Management LLC - Defense World

Jan 08, 2025
pulisher
Jan 08, 2025

Acumen Pharmaceuticals, Inc. (NASDAQ:ABOS) Shares Bought by Barclays PLC - Defense World

Jan 08, 2025
pulisher
Jan 08, 2025

Acumen Pharmaceuticals chief medical officer sells $20,046 in stock By Investing.com - Investing.com Nigeria

Jan 08, 2025
pulisher
Jan 07, 2025

Acumen Pharmaceuticals COO Barton Russell sells $14,225 in stock - Investing.com India

Jan 07, 2025
pulisher
Jan 07, 2025

Acumen Pharmaceuticals, Inc. (NASDAQ:ABOS) COO Sells 7,636 Shares - MarketBeat

Jan 07, 2025
pulisher
Jan 07, 2025

Acumen Pharmaceuticals, Inc. (NASDAQ:ABOS) Insider Eric Siemers Sells 10,859 Shares - MarketBeat

Jan 07, 2025
pulisher
Jan 07, 2025

Acumen Pharmaceuticals, Inc. (NASDAQ:ABOS) CEO Sells $87,911.52 in Stock - MarketBeat

Jan 07, 2025
pulisher
Jan 07, 2025

Acumen Pharmaceuticals COO Barton Russell sells $14,225 in stock By Investing.com - Investing.com Nigeria

Jan 07, 2025
pulisher
Jan 07, 2025

Acumen Pharmaceuticals’ chief legal officer sells $20,505 in stock By Investing.com - Investing.com Nigeria

Jan 07, 2025
pulisher
Jan 07, 2025

Acumen Pharmaceuticals CEO sells shares worth $87,873 By Investing.com - Investing.com South Africa

Jan 07, 2025
pulisher
Jan 07, 2025

Acumen Pharmaceuticals CFO Zuga Matt sells $24,366 in stock - Investing.com

Jan 07, 2025
pulisher
Jan 07, 2025

Acumen Pharmaceuticals CEO sells shares worth $87,873 - Investing.com

Jan 07, 2025
pulisher
Jan 07, 2025

Acumen Pharmaceuticals chief medical officer sells $20,046 in stock - Investing.com

Jan 07, 2025
pulisher
Jan 06, 2025

Reviewing Acumen Pharmaceuticals (NASDAQ:ABOS) & argenx (NASDAQ:ARGX) - Defense World

Jan 06, 2025
pulisher
Jan 03, 2025

State Street Corp Has $1.28 Million Position in Acumen Pharmaceuticals, Inc. (NASDAQ:ABOS) - Defense World

Jan 03, 2025
pulisher
Dec 26, 2024

ABOS stock touches 52-week low at $1.71 amid market challenges - Investing.com Nigeria

Dec 26, 2024
pulisher
Dec 26, 2024

ABOS stock touches 52-week low at $1.71 amid market challenges By Investing.com - Investing.com South Africa

Dec 26, 2024
pulisher
Dec 18, 2024

Acumen stock touches 52-week low at $1.9 amid market challenges - Investing.com Australia

Dec 18, 2024
pulisher
Dec 17, 2024

The Manufacturers Life Insurance Company Lowers Stake in Acumen Pharmaceuticals, Inc. (NASDAQ:ABOS) - Defense World

Dec 17, 2024
pulisher
Dec 17, 2024

Acumen Pharmaceuticals, Inc. (NASDAQ:ABOS) Short Interest Update - MarketBeat

Dec 17, 2024
pulisher
Dec 13, 2024

ABOS stock touches 52-week low at $2.08 amid market challenges - Investing.com Australia

Dec 13, 2024
$352.30
price down icon 5.49%
$41.04
price up icon 0.79%
$22.36
price up icon 3.33%
$5.41
price up icon 3.84%
biotechnology ONC
$226.89
price up icon 0.08%
$120.88
price down icon 0.23%
Kapitalisierung:     |  Volumen (24h):